期刊文献+

中期因子在胃癌病人血液中的检测及其临床意义 被引量:3

The expression of midkine in serum of gastric carcinomas patients
下载PDF
导出
摘要 目的研究中期因子(MK)在胃癌患者术前、术后不同时期外周血中含量的变化及其临床意义。方法用酶联免疫吸附实验对20例健康体检者(对照组)及45例胃癌患者术前第1d、术后第7d外周血进行MK含量的检测。结果胃癌病人术前血清MK的吸光度(OD值)平均值为(0.559±0.136),术后血清MK的吸光度平均值为(0.369±0.119),对照组为(0.280±0.097),术前血清MK吸光度均高于术后血清吸光度及对照组血清吸光度,差异有统计学意义(P<0.001)。Ⅰ~Ⅱ期胃癌中的血清MK的吸光度明显低于Ⅲ~Ⅳ期胃癌(P<0.001)。结论胃癌病人血清MK明显升高,MK不仅是一种肿瘤标志物,还可能作为胃癌侵袭性及预后评价的指标。 Objective To investigate the clinical significance of midkine (MK) levels in serum of patients with gastric carcinomas before and after operationMethods The levels of Serum MK were detected using enzyme-linked immunosorbent assay (ELISA)in 20 healthy cases and 45 patients with gastric carcinomas when the day before operation and the seventh-day after operation.Results The optical density (O.D.)of MK in serum of gastric carcinomas patients before operation were significantly higher than those after operation and those in healthy controls (P〈0.001).The optical density of MK in patients with gastric carcinomas in stage Ⅰ~Ⅱ was significantly lower than that in stage Ⅲ~Ⅳ(P〈0.001).Conclusion That the levels of serum MK were markedly increased in patients with gastric carcinomas,which may serve as a tumor marker and an evaluation for invasion and prognosis after operation.
出处 《江西医药》 CAS 2008年第3期192-194,共3页 Jiangxi Medical Journal
关键词 胃癌 血清MK的吸光度 术前 术后 gastric carcinoma the optical density of the serum MK before and after opration
  • 相关文献

参考文献5

  • 1Kato m,Maeta H,katos,et al.lmmunohistochemical and in situ hybridization analyses of midkine expression in thyroid papillary carcinoma.Mod Pathol,2000,13(10) : 1060 被引量:1
  • 2Shimuda H,Nabeya Y,Tagawa M,et al,Preoperative serum midkine concentration is prognostic marker squamous cell carcinoma.Cancer sci,2003,94(7) : 628 被引量:1
  • 3Muramatsu T, Midkine and pleiotrophin: two related proteins involved in development,survival,inflammation and tumorigenesis.J Biochem, 2002,132(3):359 被引量:1
  • 4Ikematsu S,Nakagawara A,et al.Correlation of elevated level of biood midkine with poor prognostic factors of human neuroblastomas.Br J Cancer,2003, 88:1522 被引量:1
  • 5Ikematsu S,Yano A,et al.Serum midkine levels are increased in patients with various types of carcinomas.Br J Cancer,2000,83:701 被引量:1

同被引文献19

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部